The recent decision of the EPO Board of Appeal in case T-1252/20 marks a significant shift, broadening the category of products eligible for medical second-use claims. This decision has considerable
Costa Rica has signed a landmark validation agreement with the European Patent Office (EPO). This milestone makes Costa Rica the first country in Central America to allow European patents to be
To mark the 30th anniversary of the cooperation between the State intellectual Property Office of China (SIPO) and European Patent Office (EPO), several activities have taken place in Beijing, for
The European Patent Office (EPO) has hosted a ceremony to mark Morocco’s decision to start validating European patents. In a ceremony called ‘Focus Morocco’, held on Friday (March 13), the EPO and
For the last 32 years, the State Intellectual Property Office of the People’s Republic of China (SIPO) has been one of the EPO’s major international cooperation partners. Now, over three decades on
The European Patent Office (EPO) has launched a public consultation to gather feedback from stakeholders and reflect their various points of view into the upcoming strategic plan (2024–2028
forinnovation and investment. Speaking on thismomentous occasion, EPO PresidentAntónio Campinos said, "This day heralds a new dawn forpatents and innovation in Europe.It is a time when users can
stimulate research, development and investment in innovation, helping to boost growth in the EU. European Patent Office (EPO) will host a virtual ceremony at 15:00 CET, “A Welcome to the Unitary Patent” to
In the long-running dispute with Novartis over breast cancer drug Afinitor, generic drug manufacturers have now scored a major victory. The EPO Boards of Appeal have revoked a patent covering active
25.10.2023 Today, the European Patent Office (EPO) published a new patent insight report on mRNA technologies. The report summarises the results of patent analyses in the field of mRNA-based vaccines